Chemoinformaics analysis of Maleic anhydride
| Molecular Weight | 98.057 | nRot | 0 |
| Heavy Atom Molecular Weight | 96.041 | nRig | 7 |
| Exact Molecular Weight | 98.0004 | nRing | 1 |
| Solubility: LogS | 0.248 | nHRing | 1 |
| Solubility: LogP | 0.191 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 9 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 2 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 10.4196 |
| nHD | 0 | BPOL | 5.47841 |
| QED | 0.306 |
| Synth | 3.131 |
| Natural Product Likeliness | 1.447 |
| NR-PPAR-gamma | 0.735 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.008 |
| CACO-2 | -4.525 |
| MDCK | 0.0000312 |
| BBB | 0.983 |
| PPB | 0.249782 |
| VDSS | 0.353 |
| FU | 0.739495 |
| CYP1A2-inh | 0.518 |
| CYP1A2-sub | 0.08 |
| CYP2c19-inh | 0.167 |
| CYP2c19-sub | 0.162 |
| CYP2c9-inh | 0.112 |
| CYP2c9-sub | 0.78 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.315 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.195 |
| CL | 6.975 |
| T12 | 0.939 |
| hERG | 0.001 |
| Ames | 0.099 |
| ROA | 0.974 |
| SkinSen | 0.953 |
| Carcinogencity | 0.279 |
| EI | 0.869 |
| Respiratory | 0.747 |
| NR-Aromatase | 0.305 |
| Antiviral | No |
| Prediction | 0.921877 |